The Obesity and Weight Loss Certificate Program provides healthcare professionals with in-depth knowledge and practical tools to manage and treat obesity and its related health conditions. Through six comprehensive courses, participants will explore the pathophysiology of obesity, evidence-based nutritional strategies, endocrine disorders contributing to weight gain, pharmacotherapy, and interdisciplinary approaches to obesity management. The program also covers metabolic complications, including hypertension and dyslipidemia, equipping learners with the skills needed to deliver effective, patient-centered care.

Physician Credit
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 6 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 6 contact hours.

ABOM Credit
Applicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 6 Group Two CME credits toward the ABOM application requirement.

• Describe the neurohormonal mechanisms that characterize obesity as a disease and its health consequences 
• Provide patient-specific recommendations for eating patterns for health and weight loss 
• Discuss FDA-approved anti-obesity medications, including their mechanism of action, efficacy, and common side effects 
• Outline the contributions of the interdisciplinary obesity management team in obesity management 
• Explore the connection between obesity and the endocrine disorders hypothyroidism and Cushing’s syndrome 
• Identify the diagnostic criteria for hypertension and dyslipidemia in patients with obesity. 

The primary target audience includes Nurse Practitioners, Physician Assistants, and Pharmacists.The secondary target audience includes Endocrinologists and Primary Care Physicians.